Levadex

Allergan says U.S. FDA sent 2nd letter on acute migraine treatment
Yahoo/Reuters
Mon, 06/30/14 - 08:55 am
FDA
Allergan
migraines
Semprana
Levadex
Valeant Pharmaceuticals
FDA declines to approve new Allergan migraine drug
Reuters
Tue, 04/16/13 - 12:06 pm
FDA
migraines
Levadex
Allergan
4 Key Drug Approvals Expected In The Next 30 Days
investors.com
Sat, 03/16/13 - 10:55 am
Biogen Idec
BG-12
multiple sclerosis
MS
Remodulin
United Therapeutics
lung disease
Invokana
JNJ
diabetes
type 2 diabetes
Levadex
Allergan
migraine
FDA Decision On MAP's Levadex Approaching, Stock Starting To Reflect Optimism
Seeking Alpha
Thu, 01/10/13 - 11:45 am
Levadex
FDA
MAP Pharmaceuticals
migraines
MAP Pharma's Awkward FDA Silence
TheStreet.com
Thu, 11/15/12 - 11:57 am
FDA
MAP Pharmaceuticals
migraines
Levadex
An FDA Decision Is on the MAP
Motley Fool
Sat, 10/20/12 - 10:28 am
Levadex
MAP Pharmaceuticals
migraines
An FDA Decision Is on the MAP
Motley Fool
Thu, 10/18/12 - 12:50 pm
FDA
MAP Pharmaceuticals
Levadex
migraines
MAP Pharmaceuticals to make new filing for approval of inhaled migraine drug later in 2012
Yahoo/AP
Mon, 06/25/12 - 11:44 am
MAP Pharmaceuticals
migraines
Levadex
MAP Pharmaceutical: Timeline Of The NDA Resubmission
Seeking Alpha
Wed, 04/18/12 - 10:13 am
MAP Pharmaceuticals
Levadex
FDA
Map Pharmaceuticals: The Levadex Levitation
Seeking Alpha
Tue, 04/3/12 - 08:56 am
MAP Pharmaceuticals
Levadex
Allergan
migraines
FDA likely to make announcement on key MAP drug Monday
The Fly on the Wall
Fri, 03/23/12 - 12:17 pm
Levadex
FDA
MAP Pharmaceuticals
migraines
MAP Pharma: Making Money From Migraines
Seeking Alpha
Sun, 03/11/12 - 12:09 pm
MAP Pharmaceuticals
Levadex
migraines
Pain-Wracked Migraine Patients’ Unmet Needs Targeted by Map’s Inhaled Drug
Bloomberg
Tue, 03/6/12 - 11:05 am
MAP Pharmaceuticals
migraines
DHE
Levadex
Buying Map Pharmaceuticals Ahead Of FDA Decision
Seeking Alpha
Mon, 01/30/12 - 12:05 pm
FDA
MAP Pharmaceuticals
migraines
Levadex
MAP's Levadex: Blockbuster Potential With A March 26 PDUFA Date
Seeking Alpha
Thu, 12/15/11 - 09:39 am
Levadex
MAP Pharmaceuticals
FDA
migraines
22 Hot Drugs Facing FDA Approval in 2012
TheStreet.com
Tue, 11/29/11 - 09:09 am
Amarin
AMR101
Ironwood
linaclotide
Merck
Ariad
ridaforolimus
Vivus
Qnexa
Avanafil
Amgen
Xgeva
Cell Therapeutics
pixantrone
Kalydeco
Vertex
ONYX Pharmaceuticals
Carfilzomib
Pfizer
Bristol-Myers Squibb
Eliquis
Chelsea Therapeutics
Northera
Levadex
MAP Pharmaceuticals
Roche
Curis
vismodegib
Biogen Idec
Elan
Tysabri
Amylin
Bydureon
Dapagliflozin
Uplypso
Protalix BioTherapeutics
Teva Pharmaceuticals
BioSante
Bio-T-Gel
Corlux
Corcept Therapeutics
Discovery Labs
Surfaxin
MAP Pharma gets US patent for methods of achieving rapid relief of migraine and minimizing side effects based upon pharmacokinetic profile
Pharmabiz
Sun, 08/14/11 - 11:32 am
MAP Pharmaceuticals
Levadex
migraines
Tempo inhaler
Biotech Calendar: 2011-12 FDA Drug Approvals
TheStreet.com
Thu, 08/11/11 - 12:37 pm
biotech
drug approvals
FDA
Eyelea
Regeneron
Dendreon
Provenge
NuPathe
Zelrix
Adcetris
Seattle Genetics
Soliris
Alexion
Dapagliflozin
AstraZeneca
Bristol-Myers Squibb
EXPAREL
Pacira
Roche
Zelboraf
Iluvien
Alimera
Bio-T-Gel
Teva Pharmaceuticals
BioSante
Zevalin
Spectrum
ruxolitinib
Incyte
Novartis
Pfizer
crizotinib
Antares
Anturol
Bydureon
Amlyin
Eli Lilly
Alkermes
AZ-004
Alexza
Corlux
Corcept Therapeutics
Affymax
Takeda
peginesatide
Levadex
MAP Pharmaceuticals
MAP Pharmaceuticals gets $20M payment for FDA filing
Bizjournals.com
Wed, 08/3/11 - 09:40 am
FDA
MAP Pharmaceuticals
Levadex
migraines
Allergan
MAP Pharmaceuticals looks to FDA for migraine treatment approval
Medreps
Sat, 05/28/11 - 02:02 pm
MAP Pharmaceuticals
Levadex
migraines

Pages